International Journal of Endocrinology and Metabolism

Published by: Kowsar

Tehran Thyroid Study (TTS)

Atieh Amouzegar 1 , Ladan Mehran 1 , Miralireza Takyar 1 , Hengameh Abdi 1 and Fereidoun Azizi 1 , *
Authors Information
1 Endocrine Research Center and Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: October 2018, 16 (4 (Suppl)); e84727
  • Published Online: October 24, 2018
  • Article Type: Review Article
  • Received: September 1, 2018
  • Revised: October 2, 2018
  • Accepted: October 7, 2018
  • DOI: 10.5812/ijem.84727

To Cite: Amouzegar A, Mehran L, Takyar M, Abdi H, Azizi F. Tehran Thyroid Study (TTS), Int J Endocrinol Metab. 2018 ; 16(4 (Suppl)):e84727. doi: 10.5812/ijem.84727.

Abstract
Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
References
  • 1. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68. doi: 10.1111/j.1365-2265.1995.tb01894.x. [PubMed: 7641412].
  • 2. Hennessey JV, Espaillat R. Subclinical hypothyroidism: A historical view and shifting prevalence. Int J Clin Pract. 2015;69(7):771-82. doi: 10.1111/ijcp.12619. [PubMed: 25846327].
  • 3. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10:5. doi: 10.1186/1745-6215-10-5. [PubMed: 19166627]. [PubMed Central: PMC2656492].
  • 4. Azizi F, Amouzegar A, Delshad H, Tohidi M, Mehran L, Mehrabi Y. Natural course of thyroid disease profile in a population in nutrition transition: Tehran thyroid study. Arch Iran Med. 2013;16(7):418-23. [PubMed: 23808780].
  • 5. Amouzegar A, Bakhtiyari M, Mansournia MA, Etemadi A, Mehran L, Tohidi M, et al. Sex- and age-specific reference values and cutoff points for TPOAb: Tehran thyroid study. Thyroid. 2016;26(3):458-65. doi: 10.1089/thy.2015.0276. [PubMed: 26650261].
  • 6. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99. doi: 10.1210/jcem.87.2.8182. [PubMed: 11836274].
  • 7. Guan H, Shan Z, Teng X, Li Y, Teng D, Jin Y, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: Results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf). 2008;69(1):136-41. doi: 10.1111/j.1365-2265.2007.03150.x. [PubMed: 18042176].
  • 8. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, et al. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab. 2003;88(6):2880-8. doi: 10.1210/jc.2002-021592. [PubMed: 12788902].
  • 9. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: Comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med. 1991;229(5):415-20. doi: 10.1111/j.1365-2796.1991.tb00368.x. [PubMed: 2040867].
  • 10. Amouzegar A, Ghaemmaghami Z, Beigy M, Gharibzadeh S, Mehran L, Tohidi M, et al. Natural course of euthyroidism and clues for early diagnosis of thyroid dysfunction: Tehran thyroid study. Thyroid. 2017;27(5):616-25. doi: 10.1089/thy.2016.0409. [PubMed: 28071990].
  • 11. Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran thyroid study. PLoS One. 2017;12(1). e0169283. doi: 10.1371/journal.pone.0169283. [PubMed: 28052092]. [PubMed Central: PMC5215694].
  • 12. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxf). 1977;7(6):481-93. doi: 10.1111/j.1365-2265.1977.tb01340.x. [PubMed: 598014].
  • 13. Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The health study of nord-trondelag (HUNT). Eur J Endocrinol. 2000;143(5):639-47. doi: 10.1530/eje.0.1430639. [PubMed: 11078988].
  • 14. Effraimidis G, Strieder TG, Tijssen JG, Wiersinga WM. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: A prospective study. Eur J Endocrinol. 2011;164(1):107-13. doi: 10.1530/EJE-10-0785. [PubMed: 20956436].
  • 15. Abdi H, Kazemian E, Gharibzadeh S, Amouzegar A, Mehran L, Tohidi M, et al. Association between thyroid function and body mass index: A 10-year follow-up. Ann Nutr Metab. 2017;70(4):338-45. doi: 10.1159/000477497. [PubMed: 28618407].
  • 16. Liu YY, Brent GA. Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab. 2010;21(3):166-73. doi: 10.1016/j.tem.2009.11.004. [PubMed: 20015660]. [PubMed Central: PMC2831161].
  • 17. Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Thyroid function and metabolic syndrome: A population-based thyroid study. Horm Metab Res. 2017;49(3):192-200. doi: 10.1055/s-0042-117279. [PubMed: 28351085].
  • 18. Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F. Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects. Thyroid. 2014;24(11):1566-74. doi: 10.1089/thy.2014.0103. [PubMed: 25069017].
  • 19. Mehran L, Amouzegar A, Bakhtiyari M, Mansournia MA, Rahimabad PK, Tohidi M, et al. Variations in serum free thyroxine concentration within the reference range predicts the incidence of metabolic syndrome in non-obese adults: A cohort study. Thyroid. 2017;27(7):886-93. doi: 10.1089/thy.2016.0557. [PubMed: 28486021].
  • 20. Amouzegar A, Kazemian E, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. Association between thyroid hormones, thyroid antibodies and insulin resistance in euthyroid individuals: A population-based cohort. Diabetes Metab. 2015;41(6):480-8. doi: 10.1016/j.diabet.2015.04.004. [PubMed: 26049821].
  • 21. Gholampour Dehaki M, Amouzegar A, Delshad H, Mehrabi Y, Tohidi M, Azizi F. Thyroid dysfunction in patients with impaired glucose metabolism: 11 year follow up from the Tehran thyroid study. PLoS One. 2017;12(10). e0184808. doi: 10.1371/journal.pone.0184808. [PubMed: 28972979]. [PubMed Central: PMC5626423].
  • 22. Amouzegar A, Heidari M, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. The association between blood pressure and normal range thyroid function tests in a population based Tehran thyroid study. Horm Metab Res. 2016;48(3):151-6. doi: 10.1055/s-0035-1564131. [PubMed: 26671752].
  • 23. Abdi H, Gharibzadeh S, Tasdighi E, Amouzegar A, Mehran L, Tohidi M, et al. Associations between thyroid and blood pressure in euthyroid adults: A 9-year longitudinal study. Horm Metab Res. 2018;50(3):236-41. doi: 10.1055/s-0044-101756. [PubMed: 29523010].
  • 24. Amouzegar A, Kazemian E, Abdi H, Mansournia MA, Bakhtiyari M, Hosseini MS, et al. Association between thyroid function and development of different obesity phenotypes in euthyroid adults: A nine-year follow-up. Thyroid. 2018;28(4):458-64. doi: 10.1089/thy.2017.0454. [PubMed: 29620968].
  • 25. Tohidi M, Derakhshan A, Akbarpour S, Amouzegar A, Mehran L, Baghbani-Oskouei A, et al. Thyroid dysfunction states and incident cardiovascular events: The tehran thyroid study. Horm Metab Res. 2018;50(1):37-43. doi: 10.1055/s-0043-121031. [PubMed: 29132170].
  • 26. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments